Clinical and Microbiological Characteristics of Bacteremic Pneumonia Caused by Klebsiella pneumoniae
- PMID: 35811668
- PMCID: PMC9259976
- DOI: 10.3389/fcimb.2022.903682
Clinical and Microbiological Characteristics of Bacteremic Pneumonia Caused by Klebsiella pneumoniae
Abstract
Klebsiella pneumoniae is a common pathogen of nosocomial pneumonia worldwide and community-acquired pneumonia (CAP) in Asia. Previous studies have shown that K. pneumoniae bacteremic CAP is associated with high mortality. We aimed to revisit K. pneumoniae bacteremic pneumonia in the current era and determine the risk factors associated with 28-day mortality. Between January 2014 and August 2020, adult patients with K. pneumoniae bacteremic pneumonia in a medical center in Taiwan were identified. Clinical and microbiological characteristics were compared between CAP and nosocomial pneumonia. Risk factors for 28-day mortality were analyzed using multivariate logistic regression. Among 150 patients with K. pneumoniae bacteremic pneumonia, 52 had CAP and 98 had nosocomial pneumonia. The 28-day mortality was 52% for all patients, 36.5% for CAP, and 60.2% for nosocomial pneumonia. Hypervirulent K. pneumoniae was more prevalent in CAP (61.5%) than in nosocomial pneumonia (16.3%). Carbapenem-resistant K. pneumoniae was more prevalent in nosocomial pneumonia (58.2%) than in CAP (5.8%). Nosocomial pneumonia, a higher Severe Organ Failure Assessment score, and not receiving appropriate definitive therapy were independent risk factors for 28-day mortality. In conclusion, revisiting K. pneumoniae bacteremic pneumonia in the current era showed a high mortality rate. Host factors, disease severity, and timely effective therapy affect the treatment outcomes of these patients.
Keywords: Klebsiella pneumoniae; bacteremia; community-acquired pneumonia (CAP); mortality; nosocomial pneumonia (NP).
Copyright © 2022 Chen, Lin, Wu, Chou, Wang and Lin.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
-
- CLSI (2022). Performance Standards for Antimicrobial Susceptibility Testing. 32nd ed (CLSI Supplement M100). (Wayne, PA: Clinical and Laboratory Standards Institute; ).
-
- Gutiérrez-Gutiérrez B., Salamanca E., de Cueto M., Hsueh P. R., Viale P., Paño-Pardo J. R., et al. . (2017). Effect of Appropriate Combination Therapy on Mortality of Patients With Bloodstream Infections Due to Carbapenemase-Producing Enterobacteriaceae (INCREMENT): A Retrospective Cohort Study. Lancet Infect. Dis. 17 (7), 726–734. doi: 10.1016/S1473-3099(17)30228-1 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
